538 related articles for article (PubMed ID: 30126895)
1. p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2.
Cloer EW; Siesser PF; Cousins EM; Goldfarb D; Mowrey DD; Harrison JS; Weir SJ; Dokholyan NV; Major MB
Mol Cell Biol; 2018 Nov; 38(22):. PubMed ID: 30126895
[TBL] [Abstract][Full Text] [Related]
2. p62 promotes bladder cancer cell growth by activating KEAP1/NRF2-dependent antioxidative response.
Li T; Jiang D; Wu K
Cancer Sci; 2020 Apr; 111(4):1156-1164. PubMed ID: 31967368
[TBL] [Abstract][Full Text] [Related]
3. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.
Kageyama S; Saito T; Obata M; Koide RH; Ichimura Y; Komatsu M
Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29339380
[TBL] [Abstract][Full Text] [Related]
4. TAK1 Regulates the Nrf2 Antioxidant System Through Modulating p62/SQSTM1.
Hashimoto K; Simmons AN; Kajino-Sakamoto R; Tsuji Y; Ninomiya-Tsuji J
Antioxid Redox Signal; 2016 Dec; 25(17):953-964. PubMed ID: 27245349
[TBL] [Abstract][Full Text] [Related]
5. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.
Jain A; Lamark T; Sjøttem E; Larsen KB; Awuh JA; Øvervatn A; McMahon M; Hayes JD; Johansen T
J Biol Chem; 2010 Jul; 285(29):22576-91. PubMed ID: 20452972
[TBL] [Abstract][Full Text] [Related]
6. The autophagy pathway maintained signaling crosstalk with the Keap1-Nrf2 system through p62 in auditory cells under oxidative stress.
Hayashi K; Dan K; Goto F; Tshuchihashi N; Nomura Y; Fujioka M; Kanzaki S; Ogawa K
Cell Signal; 2015 Feb; 27(2):382-93. PubMed ID: 25435427
[TBL] [Abstract][Full Text] [Related]
7. NBR1-mediated p62-liquid droplets enhance the Keap1-Nrf2 system.
Sánchez-Martín P; Sou YS; Kageyama S; Koike M; Waguri S; Komatsu M
EMBO Rep; 2020 Mar; 21(3):e48902. PubMed ID: 31916398
[TBL] [Abstract][Full Text] [Related]
8. Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination.
Hast BE; Cloer EW; Goldfarb D; Li H; Siesser PF; Yan F; Walter V; Zheng N; Hayes DN; Major MB
Cancer Res; 2014 Feb; 74(3):808-17. PubMed ID: 24322982
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid inhibits HCV replication via induction of IFNα antiviral response through p62-mediated Keap1/Nrf2 signaling pathway.
Shen J; Wang G; Zuo J
Antiviral Res; 2018 Jun; 154():166-173. PubMed ID: 29656059
[TBL] [Abstract][Full Text] [Related]
10. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62.
Lau A; Wang XJ; Zhao F; Villeneuve NF; Wu T; Jiang T; Sun Z; White E; Zhang DD
Mol Cell Biol; 2010 Jul; 30(13):3275-85. PubMed ID: 20421418
[TBL] [Abstract][Full Text] [Related]
11. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.
Foster A; Scott D; Layfield R; Rea SL
Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor Signaling Induces Nrf2 Pathway Activation through p62-Triggered Keap1 Degradation.
Yin S; Cao W
Mol Cell Biol; 2015 Aug; 35(15):2673-83. PubMed ID: 26012548
[TBL] [Abstract][Full Text] [Related]
13. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
[TBL] [Abstract][Full Text] [Related]
14. HCV-induced oxidative stress by inhibition of Nrf2 triggers autophagy and favors release of viral particles.
Medvedev R; Ploen D; Spengler C; Elgner F; Ren H; Bunten S; Hildt E
Free Radic Biol Med; 2017 Sep; 110():300-315. PubMed ID: 28673615
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
16. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling.
Goode A; Rea S; Sultana M; Shaw B; Searle MS; Layfield R
Mol Cell Neurosci; 2016 Oct; 76():52-58. PubMed ID: 27554286
[TBL] [Abstract][Full Text] [Related]
17. Structural and Dynamic Characterization of Mutated Keap1 for Varied Affinity toward Nrf2: A Molecular Dynamics Simulation Study.
Cheng IC; Chen YJ; Ku CW; Huang YW; Yang CN
J Chem Inf Model; 2015 Oct; 55(10):2178-86. PubMed ID: 26348991
[TBL] [Abstract][Full Text] [Related]
18. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
Stępkowski TM; Kruszewski MK
Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
[TBL] [Abstract][Full Text] [Related]
19. Nrf2-Keap1 signaling in oxidative and reductive stress.
Bellezza I; Giambanco I; Minelli A; Donato R
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):721-733. PubMed ID: 29499228
[TBL] [Abstract][Full Text] [Related]
20. Interdisciplinary Study of the Effects of Dipeptidyl-Peptidase III Cancer Mutations on the KEAP1-NRF2 Signaling Pathway.
Matić S; Tomašić Paić A; Sobočanec S; Pinterić M; Pipalović G; Martinčić M; Matovina M; Tomić S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]